E11.3553 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

Name of the Condition

• Common Name: Type 2 Diabetes with Stable Proliferative Diabetic Retinopathy, Bilateral
• Medical Term: Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina of both eyes, with no active progression or worsening of retinal changes. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The "stable" designation indicates that the proliferative changes are not actively advancing, though ongoing monitoring is essential.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure. In the stable phase, the abnormal vessels are present but not actively proliferating or causing new complications.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Often asymptomatic in early stages.
• Blurred or distorted vision.
• Floaters or dark spots in the visual field.
• Reduced night vision or color perception.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal blood vessel changes. Fluorescein angiography may be used to evaluate abnormal vessel growth. Blood glucose and HbA1c tests confirm underlying diabetes, while visual acuity and field tests assess functional impact. The "stable" classification requires documentation of no recent progression in retinal findings.

Treatment Options

• Blood glucose control: Tight management of diabetes to prevent further retinal damage.
• Blood pressure and cholesterol management: Reduces vascular stress on the retina.
• Laser photocoagulation: Seals abnormal blood vessels to prevent leakage or bleeding.
• Anti-VEGF therapy: Injections to inhibit abnormal vessel growth (if needed).
• Regular monitoring: Ongoing eye exams to detect changes in retinopathy status.

Prognosis and Follow-Up

With proper management, vision loss can be minimized, but the condition requires lifelong monitoring. Stable proliferative retinopathy has a better prognosis than active disease, but progression to advanced stages (e.g., tractional retinal detachment) remains a risk. Follow-up typically includes semiannual eye exams, with frequency adjusted based on retinal stability and diabetes control.

Complications

• Vision loss or blindness if untreated.
• Tractional retinal detachment from scar tissue.
• Vitreous hemorrhage from fragile blood vessels.
• Macular edema (swelling) affecting central vision.

Lifestyle & Prevention

• Maintain target blood glucose levels through diet, exercise, and medication.
• Control blood pressure and cholesterol.
• Avoid smoking and limit alcohol.
• Regular eye screenings for early detection.
• Protect eyes from UV light and injury.

When to Seek Professional Help

Seek immediate care for sudden vision changes (e.g., floaters, flashes, or vision loss), eye pain, or uncontrolled blood sugar. Routine follow-ups with an ophthalmologist are essential for monitoring retinopathy progression.

Tips for Medical Coders

Document the bilateral nature of the retinopathy and confirm "stable" status (no active progression) via clinical notes or imaging. Ensure diabetes type (type 2) and retinopathy classification align with the code. Include details on eye examinations, imaging, or treatments to support accurate coding.